title: Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
abstract: Our work and the study of Bilican et al. highlight the need for complementary assays to detect subtle phenotypic differences between control and mutant induced pluripotent stem cell lines.
authors.forename: Naohiro
authors.initials: N
authors.lastname: Egawa
authors.forename: Shiho
authors.initials: S
authors.lastname: Kitaoka
authors.forename: Kayoko
authors.initials: K
authors.lastname: Tsukita
authors.forename: Motoko
authors.initials: M
authors.lastname: Naitoh
authors.forename: Kazutoshi
authors.initials: K
authors.lastname: Takahashi
authors.forename: Takuya
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Adachi
authors.forename: Takayuki
authors.initials: T
authors.lastname: Kondo
authors.forename: Keisuke
authors.initials: K
authors.lastname: Okita
authors.forename: Isao
authors.initials: I
authors.lastname: Asaka
authors.forename: Takashi
authors.initials: T
authors.lastname: Aoi
authors.forename: Akira
authors.initials: A
authors.lastname: Watanabe
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Yamada
authors.forename: Asuka
authors.initials: A
authors.lastname: Morizane
authors.forename: Jun
authors.initials: J
authors.lastname: Takahashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Ayaki
authors.forename: Hidefumi
authors.initials: H
authors.lastname: Ito
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Yoshikawa
authors.forename: Satoko
authors.initials: S
authors.lastname: Yamawaki
authors.forename: Shigehiko
authors.initials: S
authors.lastname: Suzuki
authors.forename: Dai
authors.initials: D
authors.lastname: Watanabe
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hioki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kaneko
authors.forename: Kouki
authors.initials: K
authors.lastname: Makioka
authors.forename: Koichi
authors.initials: K
authors.lastname: Okamoto
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Takuma
authors.forename: Akira
authors.initials: A
authors.lastname: Tamaoka
authors.forename: Kazuko
authors.initials: K
authors.lastname: Hasegawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Nonaka
authors.forename: Masato
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Akihiro
authors.initials: A
authors.lastname: Kawata
authors.forename: Minoru
authors.initials: M
authors.lastname: Yoshida
authors.forename: Tatsutoshi
authors.initials: T
authors.lastname: Nakahata
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Takahashi
authors.forename: Maria C N
authors.initials: MC
authors.lastname: Marchetto
authors.forename: Fred H
authors.initials: FH
authors.lastname: Gage
authors.forename: Shinya
authors.initials: S
authors.lastname: Yamanaka
authors.forename: Haruhisa
authors.initials: H
authors.lastname: Inoue
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000473:pathology*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D009046:Motor Neurons / Q000166:cytology*